Der sås ingen klinisk betydende effekt på farmakokinetikken for hverken ambrisentan eller sildenafil, og kombinationen blev tålt godt.
No clinically meaningful effects on the pharmacokinetics of ambrisentan or sildenafil were seen during a drug-drug interaction study in healthy volunteers, and the combination was well tolerated.